MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Verb naming in hypokinetic and hyperkinetic movement disorders: Preliminary results

E. Bayram, M.C. Akbostanci (Ankara, Turkey)

Meeting: 2016 International Congress

Abstract Number: 339

Keywords: Cognitive dysfunction, Dystonia: Pathophysiology, Parkinsonism

Session Information

Date: Monday, June 20, 2016

Session Title: Parkinson's disease: Non-motor symptoms

Session Time: 12:30pm-2:00pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To investigate verb naming differences in hypokinetic (Parkinson’s disease, PD) and hyperkinetic (primary cervical dystonia, PCD) movement disorders; and to determine whether different effects on action performance affect action related verb naming differently as well.

Background: Motor theory of language, suggesting that action words are associated with motor cortex, has been supported by studies showing an association between verb production and frontostriatal network. PD patients, in fact, perform worse in action (verb naming) fluency (AF) than healthy controls. AF in PCD patients, however, has not been previously investigated.

Methods: 10 PD, 10 PCD patients and 10 healthy controls (HC) performed three different verbal fluency(VF) tasks; phonemic, semantic and action. Disease severity was evaluated by Hoehn and Yahr Scale(HY) in PD and by Toronto Western Spasmodic Torticollis Rating Scale(TWSTRS)-Severity score in PCD. Patients with dementia were excluded according to MMSE (<25). Statistical analyses were done with nonparametric tests.

Results: The mean disease duration (SD) was 6,3 (1,43) in PD and 9,4 (1,95) years in PCD (p=0,18). All PD patients (100%) were in HY Stage 2 during testing. Mean TWSTRS-Severity score (SD) of PCD group was 12,57 (8,54). Groups did not differ on age, gender, and years of education (p=0,33; p=0,88; p=0,37, respectively). Phonemic fluency results did not differ in between groups (p=0,09); whereas semantic fluency and AF results were significantly different (p=0,02; p=0,03, respectively). Action fluency means of groups were in line with the hypothesis (see Table 1). Pairwise comparisons revealed significant differences between PD and PCD groups in all VF tasks (phonemic fluency p=0,03; semantic fluency p=0,04; AF p=0,02). PD and HC group comparisons only revealed a trend in AF (p=0,06). PCD and HC group comparisons only revealed a significant difference in semantic fluency (p=0,02) (see Table 2).

Table 1. Demographics and test results of Parkinson’s disease, primary cervical dystonia and healthy control groups
  PD [mean (SD)] PCD [mean (SD)] HC [mean (SD)] p value
Age 60,7 (3,04) 51,5 (4,67) 58,3 (7,51) 0,33
Gender (male/female) 6/4 5/5 5/5 0,88
Years of education 8,3 (1,23) 11,2 (1,63) 8,2 (4,24) 0,37
Disease duration 6,3 (1,43) 9,4 (1,95) n/a 0,18
Disease severity HY Stage 2 (100%) TWSTRS-Severity: 12,7 (8,54) n/a n/a
Phonemic fluency 6,46 (0,8) 11,5 (2,11) 7,26 (3,56) 0,09
Semantic fluency 12,7 (1,22) 17,4 (1,95) 10,4 (5,4) 0,02*
Action fluency 6,5 (0,78) 12,3 (2,07) 9,1 (2,96) 0,03*
PD: Parkinson’s disease patients; PCD: primary cervical dystonia patients; HC: healthy controls; SD: standard deviation; HY: Hoehn and Yahr scale; TWSTRS: Toronto Western Spasmodic Torticollis Rating Scale; n/a: not applicable; *:p<0,05.”

Table 2: Multiple comparisons of groups
  PD vs PCD (p value) PD vs HC (p value) PCD vs HC (p value)
Phonemic fluency 0,03* 0,55 0,14
Semantic fluency 0,04* 0,27 0,02*
Action fluency 0,02* 0,06 0,38
PD: Parkinson’s disease patients; PCD: primary cervical dystonia patients; HC: healthy controls; *: p<0,05“

Conclusions: According to our findings different movement disorders affecting movements differently also affect language differently. This effect is in line with motor theory; as action capability decreases action language is worsened, and as it increases action word production increases. These are only the preliminary results and a further analysis in larger patient samples will be done. Studies with various movement disorders for AF should also be conducted.

To cite this abstract in AMA style:

E. Bayram, M.C. Akbostanci. Verb naming in hypokinetic and hyperkinetic movement disorders: Preliminary results [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/verb-naming-in-hypokinetic-and-hyperkinetic-movement-disorders-preliminary-results/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/verb-naming-in-hypokinetic-and-hyperkinetic-movement-disorders-preliminary-results/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley